Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kenneth R DeVault. (2007) Pantoprazole: a proton pump inhibitor with oral and intravenous formulations. Expert Review of Gastroenterology & Hepatology 1:2, pages 197-205.
Read now
Read now
Keith G Tolman, Jane Chandramouli & John C Fang. (2000) Proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Expert Opinion on Pharmacotherapy 1:6, pages 1171-1194.
Read now
Read now
Andrew Garner & Hassan Fadlallah. (1997) Pantoprazole: a new and more specific proton pump inhibitor. Expert Opinion on Investigational Drugs 6:7, pages 885-893.
Read now
Read now
Articles from other publishers (12)
Xiangbo Meng, Xiuying Zhu, Baixue Li, Jibin Liu, Jiawei Zhao, Hua Wang, Quansheng Feng & Yue Su. (2023) Efficacy and safety of proton pump inhibitors and H2 receptor antagonists in the initial non‑eradication treatment of duodenal ulcer: A network meta‑analysis. Experimental and Therapeutic Medicine 25:6.
Crossref
Crossref
Jiaxing Zhang, Long Ge, Matt Hill, Yi Liang, Juan Xie, Dejun Cui, Xiaosi Li, Wenyi Zheng & Rui He. (2019) Standard-Dose Proton Pump Inhibitors in the Initial Non-eradication Treatment of Duodenal Ulcer: Systematic Review, Network Meta-Analysis, and Cost-Effectiveness Analysis. Frontiers in Pharmacology 9.
Crossref
Crossref
V. K. Vadgama, Y. A. Patel, T. K. Patel & C. B. Tripathi. (2011) Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junction. Autonomic and Autacoid Pharmacology 31:1-2, pages 31-35.
Crossref
Crossref
Naoki Chiba. 2010. Evidence‐Based Gastroenterology and Hepatology. Evidence‐Based Gastroenterology and Hepatology
102
138
.
Yu Jin KimJae Hee Cheon, Sang Kil LeeJie Hyun KimYong Chan Lee. (2010)
Rebamipide May Be Comparable to H
2
Receptor Antagonist in Healing Iatrogenic Gastric Ulcers Created by Endoscopic Mucosal Resection: A Prospective Randomized Pilot Study
. Journal of Korean Medical Science 25:4, pages 583.
Crossref
Crossref
Naoki Chiba. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
83
116
.
R. Tutuian, P. O. Katz, W. Bochenek & D. O. Castell. (2002) Dose‐dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers. Alimentary Pharmacology & Therapeutics 16:4, pages 829-836.
Crossref
Crossref
Paul W. Jungnickel. (2000) Pantoprazole: A new proton pump inhibitor. Clinical Therapeutics 22:11, pages 1268-1293.
Crossref
Crossref
Ulysses G. Meneghelli, Schlioma Zaterka, Luiz Paula Castro, Osvaldo Malafaia & Luiz Guilherme Costa Lyra. (2000) Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil. The American Journal of Gastroenterology 95:1, pages 62-66.
Crossref
Crossref
Raymond J Playford, Theo Podas & Irvin Modlin. (1999) Pantoprazole, Prout and the proton pump. Hospital Medicine 60:7, pages 500-504.
Crossref
Crossref
Koji Takeuchi, Akira Konaka, Masato Nishijima, Shinichi Kato & Tetsuya Yasuhiro. (2002) Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: A comparative study with omeprazole and lansoprazole. Journal of Gastroenterology and Hepatology 14:3, pages 251-257.
Crossref
Crossref
Romuald J Adamek & Thomas D Bethke. (1998) Cure of Helicobacter pylori infection and healing of duodenal ulcer: comparison of pantoprazole-based one-week modified triple therapy versus two-week dual therapy. American Journal of Gastroenterology 93:10, pages 1919-1924.
Crossref
Crossref